Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Dermatology
    • Diabetes drug...

    Diabetes drug pioglitazone beneficial in treatment of plaque psoriasis

    Written by Medha Baranwal Baranwal Published On 2019-07-16T19:10:17+05:30  |  Updated On 16 July 2019 7:10 PM IST
    Diabetes drug pioglitazone beneficial in treatment of plaque psoriasis

    Pioglitazone, an antidiabetic drug, when used alone or in combination with other therapies, exhibits similar efficacy for the treatment of plaque psoriasis -- finds a recent study published in the Journal of Dermatological Treatment. The study further found no significant differences in the side effects between Pioglitazone and control. The side effects include elevated liver enzymes, weight gain, and nausea.


    Pioglitazone was found to have a modest beneficial effect in the treatment of moderate to severe plaque psoriasis.


    Pioglitazone belongs to a class of antidiabetic drugs called thiazolidinedoniones (TZD) that is known to have potential benefits in the treatment of cutaneous and metabolic disorders associated with psoriasis. TZD activates nuclear peroxisome proliferator-activated receptors (PPAR)-c that exerts their effect by promoting the terminal differentiation of keratinocytes, inhibiting epidermal growth, and reducing inflammatory responses.


    Litao Zhang, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, China, and colleagues conducted a systematic review and meta-analysis to evaluate the efficacy of combined Pioglitazone treatment. They also pointed out 3 controversial side effects from the administration of Pioglitazone in psoriasis: elevated liver enzymes, weight gain, and nausea.


    The researchers after searching across electronic databases included 6 randomised controlled trials including 294 patients (149 received pioglitazone only and 145 received pioglitazone combination).


    Primary outcome: ≥75% improvement in the Psoriasis Area and Severity Index score from baseline (PASI 75) at 12 or 10 weeks.


    Also Read: Pioglitazone an effective option for secondary prevention of Stroke in Prediabetes

    Key findings of the study include:




    • In sub-group analysis, pioglitazone and pioglitazone combination sub-groups had significant improvement in PASI 75 score vs the placebo group.

    • Overall, the pioglitazone group had significant improvement in PASI 75 compared with placebo.

    • Pioglitazone vs placebo group did not significantly differ in the incidence of elevated liver enzymes, weight gain, and nausea.


    Also Read: Pioglitazone reduces stroke events in T2 Diabetes Mellitus

    "Pioglitazone has efficacy for the treatment of plaque psoriasis. There is no significant difference between patients treated with Pioglitazone only or in combination with other therapies," write the authors. "The incidence rate of side effects associated with Pioglitazone treatment such as elevated liver enzymes, weight gain, and nausea were not significantly different compared with the control group."


    To access the complete study log on to https://doi.org/10.1080/09546634.2019.1610552

    diabetes drugelevated liver enzymesJournal of Dermatological TreatmentLitao ZhangnauseaPASIPioglitazonepioglitazone combinationpioglitazone treatmentplaque psoriasispsoriasisPsoriasis Area and Severity Indexskin diseasesskin disordersthiazolidinedonionesWeight Gain

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok